Protein Core
蛋白质核心
基本信息
- 批准号:9899928
- 负责人:
- 金额:$ 21.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Antigen TargetingAntigensBiophysicsCell surfaceCellsComputer ModelsContractsCore ProteinCryoelectron MicroscopyCrystallographyCulture MediaCytosolDevelopmentDiseaseEngineeringEpitopesEscherichia coliGenerationsGoalsGonorrheaGuidelinesImmune EvasionImmune responseImmunologyIndustrializationInfectionInfrastructureLeadLipoproteinsLocationMapsMembraneMembrane ProteinsMethodologyMethodsMicrobiologyModelingMonoclonal AntibodiesNeisseria gonorrhoeaeNutrientPathogenesisPathway interactionsPoint MutationProductionPropertyProtein EngineeringProtein SecretionProteinsResolutionSLAM proteinSiteStructural ModelsStructureSurfaceSystemTestingTherapeuticVaccine AntigenVaccine DesignVaccine ProductionVaccinesVisionWorkX-Ray Crystallographyantimicrobialdesignhost colonizationimmunogenicimmunogenicityinnovationinsightinstrumentationnovel therapeuticsnovel vaccinespathogenpathogenic bacteriaperiplasmpreventprogramsprophylacticprotein expressionprotein purificationscale upstructural biologytoolvaccine development
项目摘要
Project Summary
The overall goal of the Protein Core is to first provide atomic resolution structural and functional insight into the
design and engineering of the proposed protein antigens from Neisseria gonorrhoeae. The second aim is to
produce the antigens with high quality and quantity in an efficient and effective manner. We aim to provide high-
resolution structural information using X-ray Crystallography and/or Cryo-Electron Microscopy and we plan to
express and purify large quantities of pure protein using our recently discovered SLAM protein secretion system.
Proteins residing the outer membrane surface of Gram-negative bacterial pathogens provide a valuable target
for the generation of antimicrobial therapeutics and prophylactics. In pathogens, many of the outer membrane
proteins are required for either nutrient acquisition or host immune evasion and therefore are essential for host
colonization or during invasive disease. At the bacterial cell surface, these outer membrane proteins provide
surface accessible epitopes that can serve as antigens in the implementation of vaccines against these
pathogens—thus an understanding of their structure and function provides useful insights into the development
of new therapeutics against Gram-negative pathogens.
Dr. Moraes' program vision is to provide an avenue to develop and produce new vaccine antigens and a novel
vaccine production system. The microbiological tools, instrumentation and infrastructure available to Dr. Moraes
and his collaborators allow him to be productive and successful at contributing to the structural biology of
membrane proteins particularly as is relates to bacterial pathogenesis and vaccine design.
项目概要
蛋白质核心的总体目标是首先提供原子分辨率的结构和功能洞察
所提出的淋病奈瑟氏菌蛋白质抗原的设计和工程。第二个目标是
以高效、有效的方式生产高质量、高产量的抗原。我们的目标是提供高
使用 X 射线晶体学和/或冷冻电子显微镜解析结构信息,我们计划
使用我们最近发现的 SLAM 蛋白分泌系统表达和纯化大量纯蛋白。
革兰氏阴性细菌病原体外膜表面的蛋白质提供了一个有价值的靶标
用于产生抗菌治疗剂和预防剂。在病原体中,许多外膜
蛋白质是获取营养或逃避宿主免疫所必需的,因此对于宿主来说至关重要
定植或侵袭性疾病期间。在细菌细胞表面,这些外膜蛋白提供
表面可及的表位可以作为针对这些疾病的疫苗实施中的抗原
病原体——因此了解它们的结构和功能可以为疾病的发展提供有用的见解
针对革兰氏阴性病原体的新疗法。
Moraes 博士的项目愿景是提供开发和生产新疫苗抗原和新型疫苗的途径
疫苗生产系统。 Moraes 博士可用的微生物工具、仪器和基础设施
和他的合作者使他能够高效并成功地为结构生物学做出贡献
膜蛋白尤其与细菌发病机制和疫苗设计有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Trevor F Moraes其他文献
Trevor F Moraes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Trevor F Moraes', 18)}}的其他基金
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 21.94万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 21.94万 - 项目类别:














{{item.name}}会员




